Page last updated: 2024-09-02

1,3-di-(1-pyrenyl)propane and 1-(2-(decylthio)ethyl)azacyclopentane-2-one

1,3-di-(1-pyrenyl)propane has been researched along with 1-(2-(decylthio)ethyl)azacyclopentane-2-one in 1 studies

Compound Research Comparison

Studies
(1,3-di-(1-pyrenyl)propane)
Trials
(1,3-di-(1-pyrenyl)propane)
Recent Studies (post-2010)
(1,3-di-(1-pyrenyl)propane)
Studies
(1-(2-(decylthio)ethyl)azacyclopentane-2-one)
Trials
(1-(2-(decylthio)ethyl)azacyclopentane-2-one)
Recent Studies (post-2010) (1-(2-(decylthio)ethyl)azacyclopentane-2-one)
21001200

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hwang, SJ; Kim, DD; Kim, JS; Lee, CH; Lee, KJ; Shin, YH1

Other Studies

1 other study(ies) available for 1,3-di-(1-pyrenyl)propane and 1-(2-(decylthio)ethyl)azacyclopentane-2-one

ArticleYear
Effects of HPE-101, a skin penetration enhancer, on human erythrocyte membranes.
    International journal of pharmaceutics, 2004, Nov-05, Volume: 285, Issue:1-2

    Topics: Adjuvants, Pharmaceutic; Binding Sites; Diffusion; Diphenylhexatriene; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Erythrocyte Membrane; Fluorescence Polarization; Hemolysis; Humans; Korea; Lipid Bilayers; Membrane Fluidity; Models, Biological; Molecular Probes; Pyrenes; Pyrroles; Skin; Spectrophotometry; Viscosity

2004